PERNIX THERAPEUTICS HOLDINGS, INC. - FORM 10-K - EX-32.1 - 906 CERTIFICATE - March 8, 2018

Attached files

file filename
EX-31.2 - CFO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-2.htm
EX-31.1 - CEO 302 CERTIFICATE - PERNIX THERAPEUTICS HOLDINGS, INC.exh31-1.htm
EX-23.1 - CONSENT - PERNIX THERAPEUTICS HOLDINGS, INC.exh23-1.htm
EX-21.1 - SUBSIDIARIES - PERNIX THERAPEUTICS HOLDINGS, INC.exh21-1.htm
EX-10.43 - WAIVER, AMENDMENT AND CONSENT AGREEMENT, DATED NOVEMBER 2, 2017, AMONG PERNIX TH - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-43.htm
EX-10.42 - OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-42.htm
EX-10.41 - OFFER LETTER, DATED SEPTEMBER 22, 2017, BY AND BETWEEN PERNIX THERAPEUTICS HOLDI - PERNIX THERAPEUTICS HOLDINGS, INC.exh10-41.htm
EX-3.2 - BYLAWS - PERNIX THERAPEUTICS HOLDINGS, INC.exh3-2.htm
10-K - 10-K - PERNIX THERAPEUTICS HOLDINGS, INC.body10k.htm

EXHIBIT 32.1

CERTIFICATION UNDER SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned certifies that this annual report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in this annual report fairly presents, in all material respects, the financial condition and results of operations of Pernix Therapeutics Holdings, Inc. for the periods covered by this annual report.

Date: March 8, 2018

 

/s/ JOHN A. SEDOR

 

 

 

John A. Sedor

 

 

 

Chairman and Chief Executive Officer
(Principal Executive Officer)

 

 

 

 

 

Date: March 8, 2018

 

/s/ ANGUS W. SMITH

 

 

 

Angus W. Smith
Senior Vice President, Chief Business Officer

 

 

 

(Principal Financial Officer)

 

 

PERNIX THERAPEUTICS HOLDINGS, INC. Reports